Bristol Continues To Refocus Marketing By Outsourcing Cefzil And Tequin

Ventiv will commit 375 reps to focus on the primary care market while Bristol will continue to sell the antibiotics to specialists in hospitals. The two companies had terminated a previous co-promotion agreement for Cefzil; the new contract is fee-for-service and does not include risk sharing.